Evidence map›Paper›PMID 42253852›Full record

ArticlePolymer science & technology (Washington, D.C.)2026

The Pivotal Step of Structure Formation and Oil-Binding Capacity of Polyglucosamine.

Jonas Dörr, Blandine Boßmann, Sebastian Heinz, Wasim Haider, Marcus Koch, Marc Schneider, Markus Gallei

Abstract read
In one paragraph

Article in Polymer science & technology (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jonas DörrPolymer Chemistry, Saarland University, 66123 Saarbrücken, Germany.ORCID https://orcid.org/0009-0001-1269-6266
Blandine BoßmannPolymer Chemistry, Saarland University, 66123 Saarbrücken, Germany.
Sebastian HeinzPolymer Chemistry, Saarland University, 66123 Saarbrücken, Germany.
Wasim HaiderCertmedica International GmbH, 63741 Aschaffenburg, Germany.
Marcus KochINM-Leibniz Institute for New Materials, 66123 Saarbrücken, Germany.
Marc SchneiderDepartment of Pharmacy, Biopharmaceutics and Pharmaceutical Technology, Saarland University, 66123 Saarbrücken, Germany.
Markus GalleiPolymer Chemistry, Saarland University, 66123 Saarbrücken, Germany.ORCID https://orcid.org/0000-0002-3740-5197

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For decades, polyglucosamine (PGA), also known as chitosan, has been used as an active ingredient in medical devices intended for body weight reduction and the control of blood lipid levels in obese patients, even though the exact mechanism of lipid binding still remains unclear. The binding capability of polyglucosamines towards dietary lipids is well documented in the literature and has been studied in-depth with respect to the physicochemical properties of the biopolymer. However, only a limited number of reliable correlations between the oil-binding capacity and material properties have been reported. In contrast, the morphology and structural nature of oil-polyglucosamine sponges have not received much attention and have been investigated only rudimentarily. Our work closes this gap and shines light on the pivotal step of structure formation and morphology in relation to oil-binding capacity. After the characterization of three batches of polyglucosamine via elemental and thermal analysis, infrared spectroscopy, and size exclusion chromatography, the oil binding capacity was determined over a range of oil-to-PGA ratios for one selected batch

Indexed as

BiopolymersChitosansFunctional PolymersOil-Binding CapacityPolyglucosaminesPorous Polymers

Identifiers

PMID42253852
PMCPMC13052576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.